Pregled bibliografske jedinice broj: 1145999
Targeted prostate biopsy using a cognitive fusion of multiparametric magnetic resonance imaging and transrectal ultrasound in patients with previously negative systematic biopsies and non-suspicious digital rectal exam
Targeted prostate biopsy using a cognitive fusion of multiparametric magnetic resonance imaging and transrectal ultrasound in patients with previously negative systematic biopsies and non-suspicious digital rectal exam // Croatian medical journal, 61 (2020), 1; 49-54 doi:10.3325/cmj.2020.61.49 (međunarodna recenzija, članak, ostalo)
CROSBI ID: 1145999 Za ispravke kontaktirajte CROSBI podršku putem web obrasca
Naslov
Targeted prostate biopsy using a cognitive fusion
of multiparametric magnetic resonance imaging and
transrectal ultrasound in patients with previously
negative systematic biopsies and non-suspicious
digital rectal exam
Autori
Kuliš, Tomislav ; Zekulić, Toni ; Alduk, Ana Marija ; Lušić, Mario ; Bulimbašić, Stela ; Ferenčak, Vladimir ; Mokos, Ivica ; Hudolin, Tvrtko ; Kaštelan, Željko
Izvornik
Croatian medical journal (0353-9504) 61
(2020), 1;
49-54
Vrsta, podvrsta i kategorija rada
Radovi u časopisima, članak, ostalo
Ključne riječi
targeted prostate biopsy ; cognitive fusion biopsy ; prostate cancer
Sažetak
Aim To compare cognitive fusion targeted and systematic prostate biopsy in patients with repeated negative systematic biopsy but persistent clinical suspicion for prostate cancer. Methods The study enrolled 63 patients with at least one previously negative systematic biopsy who underwent targeted prostate biopsy using multiparametric magnetic resonance imaging (mpMRI) and transrectal ultrasound (TRUS) in addition to standardized systematic biopsy from July 2016 to May 2018. Multiparametric MRI was performed with 3 Tesla device by uro-radiologists experienced in prostate cancer. Lesions with Prostate Imaging Reporting and Data System 3, 4, and 5 were considered suspicious. Targeted biopsies were performed with cognitive fusion of TRUS and mpMRI. Results Prostate cancer detection, using either targeted or systematic biopsy, was 60.32%. Targeted biopsies were positive in 52.38% and systematic biopsies in 47.62% of patients. The median highest percentage of cancer involvement per biopsy core was significantly higher in targeted cylinders. The biopsies obtained by using the two techniques did not significantly differ in Gleason score. Conclusion Cognitive targeted prostate biopsy based on mpMRI presents a valuable addition to systematic biopsy in patients with repeated negative systematic biopsies but persistent clinical suspicion of prostate cancer.
Izvorni jezik
Engleski
Znanstvena područja
Kliničke medicinske znanosti, Biotehnologija u biomedicini (prirodno područje, biomedicina i zdravstvo, biotehničko područje)
POVEZANOST RADA
Ustanove:
Medicinski fakultet, Zagreb
Profili:
Toni Zekulić
(autor)
Ana Marija Alduk
(autor)
Tvrtko Hudolin
(autor)
Tomislav Kuliš
(autor)
Željko Kaštelan
(autor)
Ivica Mokos
(autor)
STELA BULIMBAŠIĆ
(autor)
Citiraj ovu publikaciju:
Časopis indeksira:
- Current Contents Connect (CCC)
- Web of Science Core Collection (WoSCC)
- Science Citation Index Expanded (SCI-EXP)
- SCI-EXP, SSCI i/ili A&HCI
- Scopus
- MEDLINE